Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Dianthus Therapeutics Inc (DNTH)

Dianthus Therapeutics Inc (DNTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Dianthus Therapeutics Inc 7 Times Square 43rd Floor New York NY 10036 USA

www.dianthustx.com Employees: 53 P: 929-999-4055

Description:

Dianthus Therapeutics Inc. is a privately-held, clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics. Dianthus Therapeutics Inc., formerly known as Magenta Therapeutics Inc., is based in CAMBRIDGE, Mass.

Key Statistics

Overview:

Market Capitalization, $K 691,386
Enterprise Value, $K 559,056
Shares Outstanding, K 29,597
Annual Sales, $ 2,830 K
Annual Net Income, $ -43,560 K
Last Quarter Sales, $ 2,170 K
Last Quarter Net Income, $ -25,170 K
EBIT, $ -82,770 K
EBITDA, $ -83,840 K
60-Month Beta 1.84
% of Insider Shareholders 16.56%
% of Institutional Shareholders 47.53%
Float, K 24,696
% Float 83.44%
Short Volume Ratio 0.40

Growth:

1-Year Return 101.38%
3-Year Return -78.18%
5-Year Return -89.46%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 83.13%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.74 on 11/07/24
Next Earnings Date 11/14/24
Earnings Per Share ttm -2.50
EPS Growth vs. Prev Qtr -45.10%
EPS Growth vs. Prev Year 80.42%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-16 on 09/12/23

DNTH Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -21.68%
Return-on-Assets % -20.88%
Profit Margin % -1,539.22%
Debt/Equity 0.00
Price/Sales 266.96
Price/Cash Flow N/A
Price/Book 2.29
Book Value/Share 11.50
Interest Coverage -1.40
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar